Company Overview and News

3
TRTC / Terra Tech Corp. 424B5 (Prospectus)

2018-10-19 sec.gov
trtc_424b5.htm Filed Pursuant to Rule 424(b)(5) Registration No. 333-227219 Prospectus Supplement (To Prospectus Dated October 11, 2018) TERRA TECH CORP. $4,600,000 of Shares Common Stock
TRTC

42
30 Marijuana Stocks to Buy as the Future Turns Green

2018-10-17 investorplace - 4
When it comes to cannabis, we’ve come a long way since former President Bill Clinton denied ever inhaling. With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible.
IGCIW MNTR IGC ACBFF DTK HEMP CANN LXX CVSI CBIS SRNA LDSYF MJNA APH AMMJ ACAN ABBV SMG LXRP INQD MDCL MSC.H CARA RMHB POTN ACB IIPR IMLFF KAYS PKPH TRTC GRNH ABBV APHQF

3
TRTC / Terra Tech Corp. FORM 8-K (Current Report)

2018-10-15 sec.gov
trtc_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TRTC

3
TRTC / Terra Tech Corp. FORM 8-K (Current Report)

2018-10-15 sec.gov
trtc_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TRTC

3
Terra Tech Corp.’s Edible Garden Subsidiary to Exhibit at the Fresh Summit International Convention & Expo in Florida, October 18th – 20th

2018-10-15 globenewswire
IRVINE, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, is pleased to announce that its subsidiary, Edible Garden®, will exhibit its complete range of fresh, locally grown herbs and leafy greens at the Fresh Summit International Convention & Expo, booth #305, in Orlando, Florida from Thursday, October 18 - Saturday, October 20, 2018.
TRTC

3
TRTC / Terra Tech Corp. FORM 8-K (Current Report)

2018-10-12 sec.gov
trtc_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TRTC

3
TRTC / Terra Tech Corp. POS AM

2018-10-11 sec.gov
trtc_posam.htm As filed with the Securities and Exchange Commission on October 11, 2018 Registration No. 333-210673
TRTC

3
TRTC / Terra Tech Corp. FORM S-3/A

2018-10-10 sec.gov
trtc_s3a.htm As filed with the Securities and Exchange Commission on October 10, 2018 Registration No. 333-227219
TRTC

3
TRTC / Terra Tech Corp. FORM S-3/A

2018-10-05 sec.gov
trtc_s3a.htm As filed with the Securities and Exchange Commission on October 5, 2018 Registration No. 333-227219
TRTC

3
TRTC / Terra Tech Corp. FORM 8-K (Current Report)

2018-09-28 sec.gov
trtc_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TRTC

3
TRTC / Terra Tech Corp. FORM 8-K (Current Report)

2018-09-26 sec.gov
trtc_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TRTC

3
TRTC / Terra Tech Corp. FORM 8-K (Current Report)

2018-09-24 sec.gov
trtc_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TRTC

56
30 Marijuana Stocks to Buy as the Future Turns Green

2018-09-23 investorplace - 18
When it comes to cannabis, we’ve come a long way since former President Bill Clinton denied ever inhaling. With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible.
IGCIW MNTR IGC ACBFF DTK HEMP CANN LXX CVSI CBIS SRNA LDSYF MJNA APH AMMJ ACAN ABBV SMG LXRP INQD MDCL MSC.H CARA RMHB POTN ACB IIPR IMLFF KAYS PKPH TRTC GRNH ABBV APHQF

3
TRTC / Terra Tech Corp. FORM 8-K (Current Report)

2018-09-10 sec.gov
trtc_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TRTC

3
TRTC / Terra Tech Corp. FORM S-3

2018-09-07 sec.gov
trtc_s3.htm As filed with the Securities and Exchange Commission on September 7, 2018 Registration No. 333-__________
TRTC

TRTC: Terra Tech Stock Analysis and Research Report

2017-11-16 - Asif

Terra Tech is a holding company with the following subsidiaries: Edible Garden Corp., a Nevada corporation (“Edible Garden”); MediFarm, LLC, a Nevada limited liability company (“MediFarm”); MediFarm I, LLC, a Nevada limited liability company (“MediFarm I”); MediFarm I Real Estate, LLC, a Nevada limited liability company (“MediFarm I RE”); MediFarm II, LLC, a Nevada limited liability company (“MediFarm II”); IVXX, LLC, a Nevada limited liability company (“IVXX LLC”); IVXX, Inc., a California corporation (“IVXX Inc.”; together with IVXX LLC, “IVXX”); Blüm San Leandro, a California corporation (“Blüm San Leandro”); Black Oak Gallery, a California corporation (“Black Oak”); GrowOp Technology Ltd., a Nevada corporation (“GrowOp Technology”); EG Transportation, LLC, a Nevada limited liability company (“EG Transportation”); and MediFarm So Cal, Inc., a California mutual benefit corporation (“MediFarm SoCal”) History and Background On Febru...

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TRTC / Terra Tech Corp. on message board site Silicon Investor.

TRTC - All the Characteristics of a Winner TRTC - All the Characteristics of a Winner TRTC - All the Characteristics of a Winner
CUSIP: 88102J209